We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+10.56%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$120B
AUM Growth
+$5B
(+4.4%)
Cap. Flow
-$4.23B
Cap. Flow
% of AUM
-3.53%
Top 10 Holdings %
Top 10 Hldgs %
33.52%
Holding
335
New
4
Increased
58
Reduced
216
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$227M |
| 2 |
GSK
GSK
|
+$68.2M |
| 3 |
Elanco Animal Health
ELAN
|
+$48.2M |
| 4 |
Intel
INTC
|
+$45M |
| 5 |
Capri Holdings
CPRI
|
+$44.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$764M |
| 2 |
Microsoft
MSFT
|
+$272M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$262M |
| 4 |
Caterpillar
CAT
|
+$148M |
| 5 |
Novartis
NVS
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 31.41% |
| 2 | Technology | 30.05% |
| 3 | Industrials | 12.22% |
| 4 | Consumer Discretionary | 9.43% |
| 5 | Financials | 7.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
BridgeBio Pharma
BBIO
$16.5B
| $12M | 0.01% |
696,092
-43,900
| -6% | -$661K |
|
252
Dollar General
DG
$27.9B
| $11.1M | 0.01% |
65,350
+4,100
| +7% | +$811K |
|
253
Merck
MRK
$318B
| $11.1M | 0.01% |
96,100
-4,800
| -5% | -$545K |
|
254
O'Reilly Automotive
ORLY
$76.3B
| $10.5M | 0.01% |
165,000
| – | – |
|
255
Roblox
RBLX
$27B
| $10.4M | 0.01% |
256,950
-1,400
| -0.5% | -$56.2K |
|
256
Gibraltar Industries
ROCK
$1.49B
| $10.1M | 0.01% |
161,200
-85,900
| -35% | -$4.65M |
|
|
GTM
257
ZoomInfo Technologies
GTM
$1.22B
| $9.85M | 0.01% |
388,119
+109,550
| +39% | +$2.59M |
|
258
DoorDash
DASH
$93.7B
| $9.73M | 0.01% |
127,290
-15,400
| -11% | -$1.02M |
|
|
CYBR
259
DELISTED
CyberArk
CYBR
| $9.65M | 0.01% |
61,750
+150
| +0.2% | +$21.5K |
|
|
PRO
260
DELISTED
PROS Holdings
PRO
| $9.51M | 0.01% |
308,740
-5,520
| -2% | -$155K |
|
261
Omnicell
OMCL
$1.68B
| $9.19M | 0.01% |
124,707
| – | – |
|
262
Enovis
ENOV
$1.53B
| $9.17M | 0.01% |
143,066
| – | – |
|
263
UnitedHealth
UNH
$370B
| $9.17M | 0.01% |
19,084
| – | – |
|
264
Leslie's
LESL
$11M
| $9.17M | 0.01% |
48,840
| – | – |
|
265
ESAB
ESAB
$5.71B
| $8.82M | 0.01% |
132,565
| – | – |
|
266
Rapid7
RPD
$773M
| $8.55M | 0.01% |
188,850
-4,750
| -2% | -$220K |
|
267
nLIGHT
LASR
$3.17B
| $8.08M | 0.01% |
524,260
-105,114
| -17% | -$1.28M |
|
268
Health Catalyst
HCAT
$128M
| $7.52M | 0.01% |
601,434
+11,100
| +2% | +$132K |
|
|
AMK
269
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $7.47M | 0.01% |
251,700
| – | – |
|
270
Knight Transportation
KNX
$11.4B
| $7.46M | 0.01% |
134,200
+52,500
| +64% | +$2.93M |
|
271
AutoZone
AZO
$51.1B
| $6.86M | 0.01% |
2,750
| – | – |
|
272
Griffon
GFF
$4.86B
| $6.74M | 0.01% |
+167,300
| New | +$5.49M |
|
273
Repligen
RGEN
$9.25B
| $6.7M | 0.01% |
47,379
| – | – |
|
274
EPR Properties
EPR
$4.77B
| $6.53M | 0.01% |
139,600
-4,600
| -3% | -$194K |
|
275
Hertz
HTZ
$809M
| $6.43M | 0.01% |
349,800
| – | – |
|
Similar funds
VAM
Primecap Management's Q2 2023 Portfolio in Review
As of Q2 2023, Primecap Management held 335 positions worth $120B, up 4.4% from $115B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management withdrew a net $4.23B in Q2 2023, closing 7 positions and reducing 216 holdings. Its most notable exit was Maxar Technologies Inc. Common Stock, an estimated $27M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Industrials.
Against the trend, Primecap Management opened a new position in Sphere Entertainment worth $17.1M.
- Primecap Management's largest Q2 2023 buy was Sphere Entertainment: 623,078 shares worth $17.1M.
- Primecap Management added most to Seagen Inc. Common Stock in Q2 2023, an estimated $227M increase.
- Primecap Management's biggest Q2 2023 reduction was Eli Lilly, cutting an estimated $764M.
- Primecap Management fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $27M.
- Primecap Management's ten largest holdings make up 34% of its $120B portfolio in Q2 2023.
- Primecap Management opened 4 new positions and closed 7 in Q2 2023.
- Primecap Management's portfolio value rose 4.4% quarter-over-quarter to $120B.
Based on Primecap Management's 13F filing for Q2 2023, filed 11 Aug 2023.